Matches in SemOpenAlex for { <https://semopenalex.org/work/W2336264162> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2336264162 endingPage "365" @default.
- W2336264162 startingPage "359" @default.
- W2336264162 abstract "Due to the intimate relationship between liver and kidney disease in hepatitis C virus (HCV) infection, treatment options for HCV-positive patients at any stage of chronic kidney disease (CKD) are essential. The availability of second-generation, direct-acting antiviral (DAA) combinations has allowed for the advent of interferon-sparing treatment regimens with shorter durations and minimal side effects. While many of the second-generation DAAs are principally metabolized by the hepatic system, dosing in severe renal impairment (creatinine clearance [CrCl] <30 mL/min) or dialysis has remained questionable due to limited experience. New evidence regarding the use of these agents in renal impairment continues to become available, as real-world experience with these treatment regimens is reported. Simeprevir, ledipasvir, paritaprevir, ombitasvir, dasabuvir, and daclatasvir have data to suggest safety in end-stage renal disease. While safety and efficacy with sofosbuvir remains uncertain, data are now available to support utilizing a dose adjustment when glomerular filtration rates are <30 mL/min. Upcoming regimens grazoprevir/elbasvir and daclatasvir/asunaprevir/beclavubir may provide further options for patients with advanced kidney disease, and ongoing studies will continue to provide guidance for this unique patient population. This article will review the currently available literature, including the newest emerging evidence, on the use of second-generation DAAs in CKD stages 3 to 5 and dialysis." @default.
- W2336264162 created "2016-06-24" @default.
- W2336264162 creator A5004900389 @default.
- W2336264162 creator A5030817739 @default.
- W2336264162 creator A5034869825 @default.
- W2336264162 date "2016-02-22" @default.
- W2336264162 modified "2023-09-24" @default.
- W2336264162 title "New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment" @default.
- W2336264162 cites W1599085838 @default.
- W2336264162 cites W1968974532 @default.
- W2336264162 cites W1973258213 @default.
- W2336264162 cites W1984570183 @default.
- W2336264162 cites W2010316858 @default.
- W2336264162 cites W2010430849 @default.
- W2336264162 cites W2013730096 @default.
- W2336264162 cites W2061364273 @default.
- W2336264162 cites W2072480989 @default.
- W2336264162 cites W2106791445 @default.
- W2336264162 cites W2113864802 @default.
- W2336264162 cites W2124509162 @default.
- W2336264162 cites W2131872950 @default.
- W2336264162 cites W2145623055 @default.
- W2336264162 cites W2395546240 @default.
- W2336264162 cites W4211051574 @default.
- W2336264162 doi "https://doi.org/10.1177/0897190016632128" @default.
- W2336264162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26902648" @default.
- W2336264162 hasPublicationYear "2016" @default.
- W2336264162 type Work @default.
- W2336264162 sameAs 2336264162 @default.
- W2336264162 citedByCount "10" @default.
- W2336264162 countsByYear W23362641622016 @default.
- W2336264162 countsByYear W23362641622017 @default.
- W2336264162 countsByYear W23362641622018 @default.
- W2336264162 countsByYear W23362641622019 @default.
- W2336264162 countsByYear W23362641622021 @default.
- W2336264162 crossrefType "journal-article" @default.
- W2336264162 hasAuthorship W2336264162A5004900389 @default.
- W2336264162 hasAuthorship W2336264162A5030817739 @default.
- W2336264162 hasAuthorship W2336264162A5034869825 @default.
- W2336264162 hasConcept C126322002 @default.
- W2336264162 hasConcept C159047783 @default.
- W2336264162 hasConcept C159641895 @default.
- W2336264162 hasConcept C177713679 @default.
- W2336264162 hasConcept C2522874641 @default.
- W2336264162 hasConcept C2775999097 @default.
- W2336264162 hasConcept C2776408679 @default.
- W2336264162 hasConcept C2776979040 @default.
- W2336264162 hasConcept C2777100407 @default.
- W2336264162 hasConcept C2778390639 @default.
- W2336264162 hasConcept C2778653478 @default.
- W2336264162 hasConcept C2778785139 @default.
- W2336264162 hasConcept C2778867932 @default.
- W2336264162 hasConcept C2778986448 @default.
- W2336264162 hasConcept C2779978075 @default.
- W2336264162 hasConcept C2780040827 @default.
- W2336264162 hasConcept C2908647359 @default.
- W2336264162 hasConcept C71924100 @default.
- W2336264162 hasConcept C99454951 @default.
- W2336264162 hasConceptScore W2336264162C126322002 @default.
- W2336264162 hasConceptScore W2336264162C159047783 @default.
- W2336264162 hasConceptScore W2336264162C159641895 @default.
- W2336264162 hasConceptScore W2336264162C177713679 @default.
- W2336264162 hasConceptScore W2336264162C2522874641 @default.
- W2336264162 hasConceptScore W2336264162C2775999097 @default.
- W2336264162 hasConceptScore W2336264162C2776408679 @default.
- W2336264162 hasConceptScore W2336264162C2776979040 @default.
- W2336264162 hasConceptScore W2336264162C2777100407 @default.
- W2336264162 hasConceptScore W2336264162C2778390639 @default.
- W2336264162 hasConceptScore W2336264162C2778653478 @default.
- W2336264162 hasConceptScore W2336264162C2778785139 @default.
- W2336264162 hasConceptScore W2336264162C2778867932 @default.
- W2336264162 hasConceptScore W2336264162C2778986448 @default.
- W2336264162 hasConceptScore W2336264162C2779978075 @default.
- W2336264162 hasConceptScore W2336264162C2780040827 @default.
- W2336264162 hasConceptScore W2336264162C2908647359 @default.
- W2336264162 hasConceptScore W2336264162C71924100 @default.
- W2336264162 hasConceptScore W2336264162C99454951 @default.
- W2336264162 hasIssue "3" @default.
- W2336264162 hasLocation W23362641621 @default.
- W2336264162 hasLocation W23362641622 @default.
- W2336264162 hasOpenAccess W2336264162 @default.
- W2336264162 hasPrimaryLocation W23362641621 @default.
- W2336264162 hasRelatedWork W1881020383 @default.
- W2336264162 hasRelatedWork W2293984687 @default.
- W2336264162 hasRelatedWork W2323574296 @default.
- W2336264162 hasRelatedWork W2340307424 @default.
- W2336264162 hasRelatedWork W2485759496 @default.
- W2336264162 hasRelatedWork W2565807151 @default.
- W2336264162 hasRelatedWork W2587635005 @default.
- W2336264162 hasRelatedWork W2593539364 @default.
- W2336264162 hasRelatedWork W2608524881 @default.
- W2336264162 hasRelatedWork W2618173141 @default.
- W2336264162 hasVolume "30" @default.
- W2336264162 isParatext "false" @default.
- W2336264162 isRetracted "false" @default.
- W2336264162 magId "2336264162" @default.
- W2336264162 workType "article" @default.